GENENTECH

Genentech BioOncology, a leading biotechnology company, is committed to changing the way cancer is treated by establishing a broad oncology portfolio of innovative, targeted therapies with the goal of improving patients' lives. The company is the leading provider of anti-tumor therapeutics in the United States. Some of its groundbreaking developments include agents that treat the following: breast cancer, colorectal cancer, lung cancer, lymphoma and pancreatic cancer. The company has a robust pipeline of potential oncology therapies with a focus on four key areas: angiogenesis, apoptosis (i.e., programmed cell death), the HER pathway, and B-cell biology.